A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Lisdexamfetamine Dimesylate Augmentation for Major Depressive Disorder in Adults With Inadequate Response to Antidepressant Therapy

Journal of Psychopharmacology - United States
doi 10.1177/0269881117722998